Analyst Alerts: Achillion Pharmaceuticals, Allscripts, Thoratec, Frontline April 4th

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN): Piper recommends that investors buy Achillion (NASDAQ:ACHN) on any weakness following its presentations of data at EASL, as the firm believes that data from Abbott Pharmaceuticals (NYSE:ABT) on its HCV treatment are impressive and validates Achillion’s potential future HCV treatment.The firm views Achillion as a likely takeover target and maintains an Overweight rating on the stock.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX): Allscripts shares defended at Sterne Agee

Thoratec Corp. (NASDAQ:THOR): Thoratec recall likely same as voluntary recall in March, says Leerink

Frontline Ltd. (NYSE:FRO): Dahlman Rose is positive on tankers, especially Frontline (NYSE:FRO) and Nordic American Tanker (NYSE:NAT) given the Saudi discount program for May crude.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.